StonvexLoading…
StonvexStonvexStonvexCore line items from VVX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.48B | $4.32B | $3.96B | $2.89B |
Operating Income | $194.27M | $159.20M | $124.42M | $55.77M |
Net Income | $77.88M | $34.68M | $-22.57M | $-14.33M |
EPS (Diluted) | $2.45 | $1.08 | $-0.73 | $-0.68 |
Total Assets | $3.28B | $3.23B | $3.08B | $3.23B |
Total Liabilities | $2.20B | $2.20B | $2.09B | $2.24B |
Cash & Equivalents | $368.99M | $268.32M | $72.65M | $116.07M |
Free Cash Flow OCF − CapEx | $170.07M | $242.45M | $162.95M | $81.07M |
Shares Outstanding | 31.17M | 31.56M | 31.19M | 30.47M |